Skip to main content

IDWeek 2022 Main banner

Tweets by IDWeek 2022

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Back

Melissa Aldinger, PharmD

Vir Biotechnology, Inc.

Disclosure(s): Vir Biotechnology: Employee, Stocks/Bonds

Poster(s):

304 - Viral resistance analysis in the COMET-PEAK study: sotrovimab treatment in participants with mild-to-moderate COVID-19
Thursday, October 20, 2022
12:15 PM – 1:30 PM US ET
1150 - Resistance Analysis in the COMET-TAIL Study: Participants with Mild-to-Moderate COVID-19 Treated with Intramuscular or Intravenous Sotrovimab
Friday, October 21, 2022
12:15 PM – 1:30 PM US ET
1154 - Safety, Tolerability, and Viral Pharmacodynamics of the IgG Monoclonal Antibody Sotrovimab Administered via Intramuscular Injection for the Treatment of Early Mild-to-Moderate COVID-19
Friday, October 21, 2022
12:15 PM – 1:30 PM US ET